Synthesis, antimycobacterial activity and 3-D QSAR studies of some new derivatives of p-hydroxybenzohydrazide

QSAR and Combinatorial Science

Volumn 28, Issue 11-12, 2009, Pages 1405-1417

  Bhole, Ritesh P ^a   Bhusari, Kishore P ^a  

^a Nagar Yuwak Shikshan Sanstha   (India)

Author keywords

3 D QSAR; Antimicrobial; Drug design; Medicinal chemistry; p Hydroxybenzohydrazide; PHASE; Thiazolidinones; Thiazoline

Indexed keywords

4 HYDROXYBENZOHYDRAZIDE DERIVATIVE; HYDRAZIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BINDING AFFINITY; DRUG SYNTHESIS; INFECTION; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHARMACOPHORE; PRIORITY JOURNAL; QUANTITATIVE STRUCTURE ACTIVITY RELATION;

MYCOBACTERIUM TUBERCULOSIS;

EID: 76049089957     PISSN: 1611020X     EISSN: 16110218     Source Type: Journal    
DOI: 10.1002/qsar.200960064     Document Type: Article

References (27)

1. B. R. Bloom, Nature 1992, 358, 538-539.
2. Y. A. Veselov, E. I. Krasnikova, Antibiot. Khimioter. 1992, 37, 13-15.
3. D. Sinder, D. V. Dooley, Heart Lung 1993, 22, 365-369.
4. B. M. Pukhlik, B. Mszajek, Probl. Tuberk. 1991, 6, 46-47.
5. N. M. Rudoi, T. A. Smailova, Probl. Tuberk. 1991, 6, 32-5.
6. A. G. Khomenko, Probl. Tuberk. 1988, 8, 53-57.
7. WHO Tuberculosis Programme, World Health Organization, Geneva 1994, Abstr. 179.
8. A. Kaur, P. G. Babu, J. Acquired Immune Def. Syndr. 1990, 5, 883-889.
9. A. U. Tulegenova, L. A. Kayukova, Klinitsist 1996, 4, 10-28.
10. M. Rollas, M. Kiraz, Eur. J. Med. Chem. 1999, 34, 1093-1100.
11. T. A. Vincent, Int. J. Antimicrob. Agents 2000, 16, 317.
12. Y. T. Tan, D. J. Tillett, I. A. Mckay, Mol. Med. Today 2000, 6, 309.
13. A. M. Omar, N. H. Eshba, J. Pharm. Sci. 1984, 73, 1166.
14. A. Masunari, L. Costa, Bioorg. Med. Chem. 2007, 15, 4229-4236.
15. S. P. Sihgh, S. S. Parmar, K. Raman, V. I. Stenherb, Chem. Pharm. Bull. 1981, 81, 197.
16. P. B. Patel, J. T. Trivedi, Ind. Chem. Soc. 1987, 54, 765.
17. D. M. Vittoria, O. Mazzoni, E. Piscopo, A. Caligmano, A. J. Bolognese, Med. Chem. 1992, 35, 2910.
18. A. M. Omar, N. H. Eshba, J. Pharm. Sci. 1984, 73, 1166.
19. M. Chaudhary, S. S. Parmar, S. K. Chaudhari, B. V. Ramasastry, J. Pharm. Sci. 1976, 65, 443.
20. F. A. Ragab, M. M. Hussain, M. M. Hanna, G. S. Hassan, J. Pharm. Sci. 1993, 34, 387.
21. R. P. Bhole, R. V. Chikhale, K. P. Bhusari, Int. J. Appl. Chem. 2009, 5, 67-77.
22. C. G. Bonde, N. J. Giaikwad, Bioorg. Med. Chem. 2003, 12, 2151-2161.
23. PHASE 2.0, Schrodinger, LLC, New York 2006.
24. V. Lather, J. S. Saini, R. Krishan, QSAR Comb. Sci. 2008, 27, 718-728.
25. M. Chaudhary, S. S. Parmar, S. K. Chaudhari, B. V. Ramasastry, J. Pharm. Sci. 1976, 65, 443.
26. C. B. Inderleid, in Antibiotics in Laboratory Medicine, 3rd ed. (Ed: V. Lorian), Williams and Wilkins, Baltimore 1991, p. 134.
27. N. Karali, N. Terzioglu, A. Gürsoy, Arzneim.-Forsch. Drug Res. 1998, 48(II), 7758-763.